Bio-Techne (TECH) Receivables - Net (2010 - 2026)

Bio-Techne has reported Receivables - Net for 17 years, with the latest figure at $214.6 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Net fell 9.52% year-over-year to $214.6 million; the trailing twelve-month figure through Mar 2026 stood at $214.6 million (down 9.52% YoY), and the FY2025 full-year result was $206.9 million, down 14.3% from the prior year.
• Receivables - Net for Q1 2026 stood at $214.6 million, up from $184.6 million in the prior quarter.
• The five-year high for Receivables - Net was $241.4 million in Q2 2024, with the low at $174.2 million in Q3 2022.
• Average Receivables - Net over 5 years is $208.3 million, with a median of $207.5 million recorded in 2023.
• Year-over-year, Receivables - Net surged 33.82% in 2022 and fell 17.79% in 2025.
• Tracing TECH's Receivables - Net over 5 years: stood at $184.8 million in 2022, then advanced by 12.28% to $207.5 million in 2023, then grew by 5.06% to $217.9 million in 2024, then declined by 15.29% to $184.6 million in 2025, then gained by 16.22% to $214.6 million in 2026.
• The last three Receivables - Net figures came in at $214.6 million (Q1 2026), $184.6 million (Q4 2025), and $183.9 million (Q3 2025), per Business Quant data.

Peer Comparison